OS

Oliver Schoor

IG Immatics Biotechnologies Gmbh: 92 patents #3 of 48Top 7%
📍 Rötteln, DE: #3 of 26 inventorsTop 15%
Overall (2021): #67 of 548,734Top 1%
92
Patents 2021

Issued Patents 2021

Showing 1–25 of 92 patents

Patent #TitleCo-InventorsDate
11208449 Peptides for use in immunotherapy against cancers Colette Song, Franziska Hoffgaard, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-12-28
11208434 Immunotherapy against several tumors including neuronal and brain tumors Toni Weinschenk, Claudia Trautwein, Norbert Hilf, Steffen Walter, Harpreet Singh 2021-12-28
11208448 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-12-28
11197892 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-12-14
11180532 Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers Andrea Mahr, Toni Weinschenk, Colette Song, Jens Fritsche, Harpreet Singh 2021-11-23
11179418 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-11-23
11168122 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Colette Song, Jens Fritsche, Toni Weinschenk, Harpreet Singh 2021-11-09
11155590 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-10-26
11155597 Relaxin1 derived peptides for use in immunotherapy Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Lea Stevermann 2021-10-26
11154576 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-10-26
11147839 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-10-19
11147838 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-10-19
11142556 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +2 more 2021-10-12
11141437 Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-10-12
11136352 Immunotherapy against several tumors including neuronal and brain tumors Toni Weinschenk, Claudia Trautwein, Norbert Hilf, Steffen Walter, Harpreet Singh 2021-10-05
11123370 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Colette Song, Jens Fritsche +1 more 2021-09-21
11116826 Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Toni Weinschenk, Jens Fritsche, Harpreet Singh, Andrea Mahr, Martina Ott +1 more 2021-09-14
11117941 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-09-14
11117951 Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Jens Fritsche, Harpreet Singh 2021-09-14
11111281 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-09-07
11111280 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Andrea Mahr, Toni Weinschenk, Valentina Goldfinger, Jens Fritsche, Harpreet Singh 2021-09-07
11103535 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-08-31
11083784 Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Jens Fritsche, Harpreet Singh 2021-08-10
11077142 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-08-03
11071773 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-07-27